Type Here to Get Search Results !

Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.

from US Top News and Analysis https://ift.tt/EFu7jQz

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.

Top Post Ad

Below Post Ad